Kuan Yan, Runjun Jia, Sheng Guo
This poster introduces SynAI, a state-of-the-art AI-driven solution poised to redefine the approach to predicting drug synergism in cancer cell lines. By harnessing the power of compound SMILE sequences, SynAI offers a swift, efficient, and cost-effective method for identifying promising therapeutic combinations. It signifies a leap towards a more dynamic and scalable drug discovery process, unshackled from the limitations of traditional screening methods.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-04-11
2024-03-25
landing_page
AACR 2024